Start Date
May 1, 2018
Primary Completion Date
May 1, 2020
Study Completion Date
July 1, 2020
Elvitegravir, Cobicistat, TAF, FTC
Started on day of HIV diagnosis
Efavirenz, TDF, and 3TC
Started on day of HIV diagnosis
Collaborators (2)
Gilead Sciences
INDUSTRY
Brigham and Women's Hospital
OTHER
Weill Medical College of Cornell University
OTHER
Analysis Group, Inc.
INDUSTRY
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
OTHER